Article
Pfizer, Valneva say 'positive' result for Lyme disease vaccine candidate booster
Rating:
0.0
Views:
51
Likes:
1
Library:
1
Pfizer and French pharmaceutical peer Valneva announced on Thursday that a phase 2 study for its VLA15 Lyme disease vaccine candidate showed a "strong immune response" in both children and adolescents a month after a booster shoot.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value